Nanoscale Science, Engineering, and Technology Subcommittee; Committee on Technology, National Science and Technology Council; Meeting, 53220 [2014-21201]
Download as PDF
53220
Federal Register / Vol. 79, No. 173 / Monday, September 8, 2014 / Notices
Established
2015 quotas (g)
Basic class
Noroxymorphone (for sale) ..........................................................................................................................................................
Opium (powder) ...........................................................................................................................................................................
Opium (tincture) ...........................................................................................................................................................................
Oripavine ......................................................................................................................................................................................
Oxycodone (for conversion) ........................................................................................................................................................
Oxycodone (for sale) ...................................................................................................................................................................
Oxymorphone (for conversion) ....................................................................................................................................................
Oxymorphone (for sale) ...............................................................................................................................................................
Pentobarbital ................................................................................................................................................................................
Phenazocine ................................................................................................................................................................................
Phencyclidine ...............................................................................................................................................................................
Phenmetrazine .............................................................................................................................................................................
Phenylacetone .............................................................................................................................................................................
Racemethorphan .........................................................................................................................................................................
Remifentanil .................................................................................................................................................................................
Secobarbital .................................................................................................................................................................................
Sufentanil .....................................................................................................................................................................................
Tapentadol ...................................................................................................................................................................................
Thebaine ......................................................................................................................................................................................
1,475,000
112,500
687,500
35,000,000
8,350,000
137,500,000
29,000,000
7,750,000
35,000,000
6
19
3
9,375,000
3
3,750
215,003
6,255
12,500,000
125,000,000
List I Chemicals
Ephedrine (for conversion) ..........................................................................................................................................................
Ephedrine (for sale) .....................................................................................................................................................................
Phenylpropanolamine (for conversion) ........................................................................................................................................
Phenylpropanolamine (for sale) ...................................................................................................................................................
Pseudoephedrine (for conversion) ..............................................................................................................................................
Pseudoephedrine (for sale) .........................................................................................................................................................
The Deputy Administrator also
establishes aggregate production quotas
for all other schedule I and II controlled
substances included in 21 CFR 1308.11
and 1308.12 at zero. In accordance with
21 CFR 1303.13 and 21 CFR 1315.13,
upon consideration of the relevant
factors, the Deputy Administrator may
adjust the 2015 aggregate production
quotas and assessment of annual needs
as needed.
Dated: September 2, 2014.
Thomas M. Harrigan,
Deputy Administrator.
[FR Doc. 2014–21280 Filed 9–5–14; 8:45 am]
BILLING CODE 4410–09–P
OFFICE OF SCIENCE AND
TECHNOLOGY POLICY
National Nanotechnology Coordination
Office
Nanoscale Science, Engineering, and
Technology Subcommittee; Committee
on Technology, National Science and
Technology Council; Meeting
rmajette on DSK2TPTVN1PROD with NOTICES
ACTION:
Notice of public meeting.
The National Nanotechnology
Coordination Office (NNCO), on behalf
of the Nanoscale Science, Engineering,
and Technology (NSET) Subcommittee
of the Committee on Technology,
National Science and Technology
Council (NSTC), will hold a technical
SUMMARY:
VerDate Mar<15>2010
15:14 Sep 05, 2014
Jkt 232001
interchange meeting entitled ‘‘Realizing
the Promise of Carbon Nanotubes—
Challenges, Opportunities and the
Pathway to Commercialization’’ on
September 15, 2014. The meeting will
be sponsored by the National
Nanotechnology Initiative (NNI) and cosponsored by the National Aeronautics
and Space Administration (NASA). The
objectives of this meeting are to identify,
discuss, and report the technical
barriers preventing the production of
carbon nanotube-based materials with
electrical and mechanical properties
approaching theoretical values, and to
explore ways to overcome these barriers.
Obstacles preventing the full
exploitation of the multifunctional
nature of carbon nanotube materials will
also be discussed. This one-day meeting
will assemble some of the Nation’s
leading experts in carbon nanotube
research and development, as well as
executives and experts from the Federal
government, academia, and private
sector.
The technical interchange
meeting will be held Monday,
September 15, 2014 from 8:00 a.m. until
5:15 p.m.
ADDRESSES: The technical interchange
meeting will be held at the National
Aeronautics and Space Administration
(NASA) Headquarters, 300 E Street
Southwest, Washington, DC 20546.
FOR FURTHER INFORMATION, CONTACT: Dr.
Tarek Fadel, 703–292–7926, tfadel@
DATES:
PO 00000
Frm 00059
Fmt 4703
Sfmt 9990
1,000,000
4,000,000
44,800,000
8,500,000
7,000
224,500,000
nnco.nano.gov, NNCO. Additional
information is posted at: https://
nano.gov/2014CNTTechInterchange.
Registration: Registration opens on
September 8, 2014. Due to space
limitations, pre-registration for the
technical interchange meeting is
required. Written notices of
participation by email should be sent to
dpetreski@nnco.nano.gov or mailed to
Diana Petreski, 4201 Wilson Blvd.,
Stafford II, Suite 405, Arlington, VA
22230. Please provide your full name,
title, affiliation and email or mailing
address when registering. Registration is
on a first-come, first-served basis until
capacity is reached. Written or
electronic comments should be
submitted by email to dpetreski@
nnco.nano.gov until close of business
September 10, 2014.
Meeting Accommodations:
Individuals requiring special
accommodation to access this meeting
should contact Diana Petreski at 703–
292–7922 at least five business days
prior to the meeting so that appropriate
arrangements can be made.
Ted Wackler,
Deputy Chief of Staff and Assistant Director.
[FR Doc. 2014–21201 Filed 9–5–14; 8:45 am]
BILLING CODE P
E:\FR\FM\08SEN1.SGM
08SEN1
Agencies
[Federal Register Volume 79, Number 173 (Monday, September 8, 2014)]
[Notices]
[Page 53220]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21201]
=======================================================================
-----------------------------------------------------------------------
OFFICE OF SCIENCE AND TECHNOLOGY POLICY
National Nanotechnology Coordination Office
Nanoscale Science, Engineering, and Technology Subcommittee;
Committee on Technology, National Science and Technology Council;
Meeting
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: The National Nanotechnology Coordination Office (NNCO), on
behalf of the Nanoscale Science, Engineering, and Technology (NSET)
Subcommittee of the Committee on Technology, National Science and
Technology Council (NSTC), will hold a technical interchange meeting
entitled ``Realizing the Promise of Carbon Nanotubes--Challenges,
Opportunities and the Pathway to Commercialization'' on September 15,
2014. The meeting will be sponsored by the National Nanotechnology
Initiative (NNI) and co-sponsored by the National Aeronautics and Space
Administration (NASA). The objectives of this meeting are to identify,
discuss, and report the technical barriers preventing the production of
carbon nanotube-based materials with electrical and mechanical
properties approaching theoretical values, and to explore ways to
overcome these barriers. Obstacles preventing the full exploitation of
the multifunctional nature of carbon nanotube materials will also be
discussed. This one-day meeting will assemble some of the Nation's
leading experts in carbon nanotube research and development, as well as
executives and experts from the Federal government, academia, and
private sector.
DATES: The technical interchange meeting will be held Monday, September
15, 2014 from 8:00 a.m. until 5:15 p.m.
ADDRESSES: The technical interchange meeting will be held at the
National Aeronautics and Space Administration (NASA) Headquarters, 300
E Street Southwest, Washington, DC 20546.
FOR FURTHER INFORMATION, CONTACT: Dr. Tarek Fadel, 703-292-7926,
tfadel@nnco.nano.gov, NNCO. Additional information is posted at: https://nano.gov/2014CNTTechInterchange.
Registration: Registration opens on September 8, 2014. Due to space
limitations, pre-registration for the technical interchange meeting is
required. Written notices of participation by email should be sent to
dpetreski@nnco.nano.gov or mailed to Diana Petreski, 4201 Wilson Blvd.,
Stafford II, Suite 405, Arlington, VA 22230. Please provide your full
name, title, affiliation and email or mailing address when registering.
Registration is on a first-come, first-served basis until capacity is
reached. Written or electronic comments should be submitted by email to
dpetreski@nnco.nano.gov until close of business September 10, 2014.
Meeting Accommodations: Individuals requiring special accommodation
to access this meeting should contact Diana Petreski at 703-292-7922 at
least five business days prior to the meeting so that appropriate
arrangements can be made.
Ted Wackler,
Deputy Chief of Staff and Assistant Director.
[FR Doc. 2014-21201 Filed 9-5-14; 8:45 am]
BILLING CODE P